Introduction {#Sec1}
============

Super-enhancers (SEs) are master regulators of cell fate which differ from basic enhancers by their ten-fold higher load of chromatin marks, their binding of mediator, their long length and their impact on nuclear organisation^[@CR1],\ [@CR2]^. The immunoglobulin heavy chain (IgH) locus undergoes multiple changes along B-cell differentiation, affecting transcription and accessibility for V(D)J recombination, somatic hypermutation (SHM) and class switch recombination (CSR)^[@CR3]^. The IgH locus is somehow unique in carrying two SEs, E~μ~ and the 3′ regulatory region (3′RR) at both ends of the constant gene cluster, which control locus remodelling along B-cell differentiation^[@CR3]^. In mature B-cells, the IgH locus assumes an enigmatic loop conformation in which these two SEs are brought in close proximity despite their 200 kb distance on the chromosome (Fig. [1a](#Fig1){ref-type="fig"})^[@CR4]^. Two mechanistic hypothesises may explain the function of this 3D chromatin structure: a bidirectional crosstalk between these two SEs allowing reciprocal activation, or a simple chromatin arch assembly that brings enhancers, promoters and switch (S) regions into close proximity to facilitate transcription, accumulation of RNA pol II, AID targeting and S junction machinery. In a third hypothesis, the E~μ~-3′RR interaction might lack any mechanistic role by passively witness transitional links, with E~μ~ on one side promoting S~μ~-S~x~ synapsis and the 3′RR stimulating the I~x~-S~x~ transcriptional unit. We investigated if these two IgH SEs were independent engines of locus remodelling simply combining their proper actions or if their functions were more strongly intermingled and required physical contact with each other. SEs are potent clusters of transcriptional enhancers and regulate the expression of key cell lineage specific genes. The 5′E~μ~ SE has clearly such a role in early developmental stages of B-cells through its key role on V(D)J recombination. Since 5′E~μ~ may be considered as a SE only in pro-B/pre-B-cells but not in mature ones, we used the qualifier of enhancer to name 5′E~μ~ at the mature B-cell stage during this study.Figure 1E~μ~ and CSR. (**a**) Schematic 3D conformation of the IgH locus during LPS-induced CSR. 3C experiments indicated that E~μ~ and the 3′RR are in close proximity in resting B cells. After appropriated stimulation the activated S acceptor region gets closer the S~μ~ donor region. Adapted from Wuerffel *et al*.^[@CR4]^. (**b**) Flow cytometry analysis of IgG~3~ and IgG~2b~ CSR in E~µ~-deficient B-cells. Cells were stimulated 4 days with LPS. Cells were labelled with anti-B220-BV421, anti-IgG~3~-FITC, anti-IgG~2b~-PE and anti-IgM-PC7 antibodies. Cells were gated on B220^+^ B-cells. One representative experiment out of four is shown. (**c**) Quantitative analysis of IgG~1~, IgG~3~ and IgG~2b~ CSR. Results are reported as mean ± SEM of 4 independent experiments. \*p \< 0.05, Mann-Whitney *U*-test. (**d**) Flow cytometry analysis of IgG~1~ CSR in E~μ~-deficient B-cells. Cells were stimulated 4 days with LPS + IL-4. Cells were labelled with anti-B220-BV421, anti-IgG~1~-PE and anti-IgM-PC7 antibodies. Cells were gated on B220^+^ B-cells. One representative experiment out of four is shown. (**e**) H3K4me3 epigenetic mark in *S* ~μ~ and *S* ~γ1~ during IgG~1~ CSR ChIP assays were performed with CD43^−^ splenic B-cells from E~μ~-deficient and *wt* mice. Cells were stimulated with LPS + IL-4 for 2 days. Background signals from mock samples with irrelevant antibody were subtracted. Values were normalized to the total input DNA. Data are the mean ± SEM of 3 independent experiments with 2 mice. (**f**) H3K4me3 epigenetic mark in *S* ~μ~ and *S* ~γ3~ during IgG~3~ CSR. Cells were stimulated with LPS for 2 days. Same protocol as in part E.
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=======

E~μ~ and CSR {#Sec3}
------------

During CSR, a chromatin loop is found with E~μ~ and 3′RR in close proximity^[@CR3],\ [@CR4]^. It is generally accepted that E~µ~ is dispensable for CSR, although some studies suggest that its deletion impacts at minor levels CSR efficiency^[@CR5]--[@CR7]^. In this study, flow cytometry analysis shows normal proportion of E~μ~-deficient γ3- and γ2b-expressing B-cells in response to LPS stimulation (Fig. [1b and c](#Fig1){ref-type="fig"}). In contrast, the significant decrease of E~μ~-deficient γ1-expressing B-cells in response to LPS + IL4 (Fig. [1c and d](#Fig1){ref-type="fig"}) could mostly be attributed to the lack of follicular B-cells previously reported in this model^[@CR7]^. These results are in accordance with the lowered serum IgG~1~ levels but normal IgG~3~/IgG~2b~ levels in this model^[@CR7]^. Specific epigenetic mark enrichment in S regions is a prerequisite for CSR^[@CR8],\ [@CR9]^. During CSR, the 3′RR SE fosters H3K4me3 histone modifications in the S acceptor but not S~μ~ donor region^[@CR10]^, suggesting another *cis*-transcriptional enhancer for this role. This role is not devolved to E~μ~ since its deletion did not affect H3K4me3 histone modifications in S~μ~ and S~γ1~ in response to LPS + IL-4 stimulation (Fig. [1e](#Fig1){ref-type="fig"}) nor in S~μ~ and S~γ3~ in response to LPS stimulation (Fig. [1f](#Fig1){ref-type="fig"}). Altogether, these data indicate that the E~μ~ enhancer is mostly dispensable for CSR and did not poise S~μ~ for CSR. The *cis*-transcriptional enhancer that poised S~μ~ for CSR is currently unknown. One might suggest the enigmatic transcriptional enhancer located between C~γ1~ and C~γ2b~ found to interact with both E~μ~ and 3′RR in pro-B cells^[@CR2],\ [@CR11],\ [@CR12]^.

E~μ~, 3′RR and respective epigenetic marks {#Sec4}
------------------------------------------

Epigenetic changes in E~μ~ and 3′RR are of importance during CSR^[@CR13]^. In this study we have focussed on H3K4me3, H3K9ac and H3K27ac epigenetic marks that are associated with active regulatory regions^[@CR14]^. Lack of the E~μ~ enhancer did not affect H3K4me3, H3K9ac and H3K27ac epigenetic marks in the four 3′RR transcriptional enhancers (hs3a; hs1,2; hs3b; hs4) during LPS-induced B-cell CSR (Fig. [2a](#Fig2){ref-type="fig"}). In turn, if deletion of the 3′RR SE had no effect on H3K4me3 and H3K27ac marks of E~μ~ (Fig. [2b](#Fig2){ref-type="fig"}), a significant decrease was found for H3K9ac. This difference between epigenetic marks may be explained by the proposed model of sequential histone modifications. Indeed, several studies suggest that tri-methylation of H3K4 is the earliest modification, and that H3K4me3 then facilitate H3 acetylation and thus establishment of chromatin openness. All these marks together may then positively regulate transcription and enhancer activation^[@CR15],\ [@CR16]^. At the mature B-cell stage, data suggest the lack of E~μ~-dependence for the 3′RR SE during CSR, and the influence of the 3′RR on the E~μ~ enhancer, a result that fits well with their different kinetics of activation, *i.e*., at the immature and mature B-cell stages for Eμ and 3′RR, respectively^[@CR3]^.Figure 2Epigenetic marks in E~μ~ and 3′RR during CSR. (**a**) H3K4me3, H3K9ac and H3K27ac epigenetic marks in the four enhancers (hs3a, hs1,2, hs3b and hs4) of the 3′RR in LPS-stimulated B-cells of E~μ~-deficient and *wt* mice. Cells were stimulated with 5 μg/ml LPS for 2 days. Data are the means ± SEM of 3 independent experiments with 2 mice. (**b**) H3K4me3, H3K9ac and H3K27ac epigenetic marks in E~μ~ in LPS-stimulated B-cells of 3′RR-deficient and *wt* mice. Same experimental protocol as in part (**a**). Data are the means ± SEM of 3 independent experiments with 2 mice. \*p \< 0.05 (Mann-Whitney *U*-test).

Mutual activation of transcription of E~μ~ and 3′RR SEs {#Sec5}
-------------------------------------------------------

The 3′RR SE controls CSR by acting on germline transcription and histone modifications^[@CR8],\ [@CR17]^, that are hallmarks of CSR accessibility. We investigated the effect of the lack of the E~μ~ enhancer or of the 3′RR SE on IgH constant gene transcription units (C~H~) in response to LPS-induced stimulation *in vitro*. RNAseq experiments showed that, except for C~μ~, C~H~ sense and antisense transcripts were dramatically reduced in 3′RR-deficient mice (Fig. [3a](#Fig3){ref-type="fig"} and Supplementary Figs [1](#MOESM1){ref-type="media"}--[3](#MOESM1){ref-type="media"}). In contrast, E~μ~ deletion had no effect on C~H~ transcription at the IgH locus. RNASeq data are presented in a quantitative way with statistics in the Supplementary Fig. [4](#MOESM1){ref-type="media"}. Non coding RNAs (ncRNAs) play an important role in the targeting of the CSR machinery and contribute to chromosomal looping^[@CR10],\ [@CR18]^. Among these ncRNAs, enhancer RNA (eRNA) are transcribed from DNA sequences of enhancer including the 3′RR and contribute to their enhancer function^[@CR19],\ [@CR20]^, and chromosomal looping^[@CR4]^. RNAseq experiments did not highlight any effect of E~μ~ deletion on both sense and antisense 3′RR eRNA levels (Fig. [2a](#Fig2){ref-type="fig"}). In contrast both sense and antisense transcription around the E~μ~ enhancer were consistently lowered in 3′RR-deficient activated B-cells. This decrease is reminiscent of the notable effect of the 3′RR SE deletion on μ transcription evidenced with quantitative PCR in resting mature B-cells^[@CR21]^. Physical E~μ~-3′RR interactions were also documented in resting B-cells^[@CR4]^. RNAseq data comparing splenic resting B-cells indicate that enhancer activity was, at this stage, already dominated by the 3′RR: while E~μ~ deletion showed no obvious effect on C~H~ transcription and 3′RR eRNAs, the 3′RR deletion does not modifies E~μ~ eRNA but still decreases μ transcripts and abrogates basal transcription of all downstream C~H~ (Fig. [2b](#Fig2){ref-type="fig"}). This confirmed a passive role for E~μ~ at the resting stage while H chain production originated from pV~H~ mostly rely on 3′RR, and more precisely on hs4^[@CR22]^.Figure 3Influence of E~µ~ and 3′RR on IgH transcription during CSR. (**a**) IgH transcription on LPS-stimulated B-cells of *wt*, Eμ-deficient and 3′RR-deficient mice. CD43-depleted splenocytes were cultured for 2 days with 5 μg LPS. RNAseq experiments were done after depletion of rRNA. Data are the mean of two independent experiments with 3 mice per genotype. (**b**) IgH transcription on resting B-cells of *wt*, Eμ-deficient and 3′RR-deficient mice. RNAseq experiments were done with CD43-depleted splenocytes after depletion of rRNA. Data are the mean of two independent experiments with 3 mice per genotype. Precise locations of I~μ~, S~μ~, C~μ~, C~δ~, I~γ3~, S~γ3~, Iγ~2b~ and S~γ2b~ are reported in Supplementary Figs [1](#MOESM1){ref-type="media"}--[3](#MOESM1){ref-type="media"}.

Discussion {#Sec6}
==========

Studies highlighted different roles and kinetics of activation for IgH SEs during B-cell development. The E~μ~ SE regulates V(D)J recombination in pro-B cells^[@CR6],\ [@CR7]^, but is not crucial for SHM and CSR in mature B-cells^[@CR23]^. The 3′RR SE regulates SHM^[@CR24]^, and conventional CSR in mature B-cells^[@CR10],\ [@CR25],\ [@CR26]^, but is dispensable for V(D)J recombination^[@CR27]^. GFP transgenic mice reported that the E~μ~ SE is active at pro-B/pre-B cell stages^[@CR28]^, while the 3′RR SE is active at immature/mature B-cell stages^[@CR29]^. Despite different roles and kinetics, the IgH locus assumes in resting B-cells and CSR an enigmatic loop conformation with the E~μ~ enhancer and the 3′RR SE in close proximity^[@CR4]^, suggesting a potential transcriptional cross-talk between these two enhancer entities. Present results strongly suggest that cross-talk is unidirectional. The 3′RR SE stands as a fully autonomous module in mature B-cells. The E~μ~ enhancer by contrast appears mostly dispensable at this stage, its deletion neither abrogating CSR-required sense/antisense germline transcription or 3′RR SE eRNA expression and activation-associated epigenetic mark enrichment. If the E~μ~ enhancer has no role on 3′RR activation during CSR, it itself shows at least partial 3′RR-dependence. Deletion of the 3′RR SE impacts E~μ~ H3K9ac activation-associated epigenetic marks and sense/anti-sense eRNA transcription.

During CSR the IgH locus assumes a loop conformation. While this conformation has obviously a major interest to simultaneously bring enhancer, SE, S regions and promoters into close proximity, our data suggest another unknown functional role, which is to place E~μ~ under the authority of the 3′RR SE. The E~μ~/S~μ~/S~x~/3′RR hub might have several successive purposes to facilitate CSR. This hub brings the S~x~ acceptor region in close proximity to the 3′RR SE, allowing for its efficient activation by acting notably on transcription and AID targeting^[@CR10]^. It support physical/functional interactions between 3′RR elements hereby building their synergy^[@CR3]^, and finally facilitates S~μ~-S~x~ synapsis, increasing the probability of a legitimate junction between donor and acceptor S regions and, in the meantime, reducing the risk of potentially oncogenic translocation^[@CR30]--[@CR32]^. Previously reported phenotypes of E~μ~- and 3′RR-deficient mice, now completed by the present study, show that both IgH enhancers can behave as completely autonomous elements with regards to chromatin marks, eRNA transcription and accessibility, with E~μ~ solely controlling early rearrangements of immature B-cells, and the 3′RR being both necessary and sufficient for late B-cell remodelling events. However in mature B-cells, this ends with E~μ~ falling under the control of the 3′RR SE and then undergoing 3′RR-dependent transcription and chromatin remodelling as almost all basic promoters of the locus. Finally, three SEs have been reported in pro-B cells: Eμ, 3′RR and an enigmatic region between C~γ1~ and C~γ2~ ^[@CR2],\ [@CR11],\ [@CR12]^. Despite that 3′RR has little role on V(D)J recombination except for silencing early transcription in pro-B cells^[@CR33]^, investigation of the cross-talk between these three SEs in pro-B cells would be of interest to reinforce our knowledge of their role at the immature B-cell maturation stage.

Material and Methods {#Sec7}
====================

Mice {#Sec8}
----

129 *wt* mice (from Charles Rivers Laboratories, France), E~μ~MAR-deficient mice^[@CR7]^, and 3′RR-deficient mice^[@CR25]^ were used. E~μ~MAR-deficient mice and 3′RR-deficient mice were in a 129 background. Our research has been approved by our local ethics committee review board (Comité Régional d'Ethique sur l′Expérimentation Animale du Limousin, Limoges, France) and carried according the European guidelines for animal experimentation.

Spleen cell cultures for B-cell activation {#Sec9}
------------------------------------------

Single-cell suspensions of CD43^−^ spleen cells of *wt*, EμMAR-deficient mice and 3′RR-deficient mice (8--12 week old, male and female) were cultured at 1 × 10^6^ cells per ml in RPMI 1640 with 10% fetal calf serum with 5 μg per ml LPS with or without 20 ng/ml IL-4. Two days LPS-stimulated cells were used for RNAseq and S~μ~/S~γ3~ ChIP experiments. Two days LPS + IL4 stimulated cells were then used for S~μ~/S~γ1~ ChIP experiments. Four days LPS- and LPS + IL4 stimulated cells were used for γ3, γ2b and γ1 CSR flow cytometry analysis, respectively.

Flow cytometry analysis {#Sec10}
-----------------------

Cultured splenic B-cells were labelled with anti-B220-BV421, anti-IgG~1~-PE, anti-IgG~3~-FITC, anti-IgG~2b~-PE and anti-IgM-PC7 antibodies for 30 min at 4 °C. Labelled cells were analyzed on a Fortessa LSR2 (Beckman Coulter) with Kaluza.

ChIP experiments {#Sec11}
----------------

ChIP experiments were done on LPS- and LPS + IL4 stimulated CD43^−^ spleen cells as previously described^[@CR10]^. In brief, 20 × 10^6^ B-cells were cross-linked at room temperature for 15 min in 15 ml PBS with 1% formaldehyde. The reaction was quenched with 0.125 M glycine. After lysis, chromatin was sonicated to 0.5--1 kb using a Vibracell 75043 (Thermo Fisher Scientific). After dilution in ChIP buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, pH 8.1, and 167 mM NaCl), chromatin was precleared by rotating for 2 h at 4 °C with 50 ml of 50% protein A/G slurry (0.2 mg per ml sheared salmon sperm DNA, 0.5 mg per ml BSA, and 50% protein A/G; Sigma). 1 × 10^6^ cell equivalents were saved as input, and 10 × 10^6^ cell equivalents were incubated overnight with anti-H3K4me3, anti-H3K9ac, anti-H3K27ac or control antibodies. Immune complexes were precipitated by the addition of protein A/G. Cross-linking was reversed by overnight incubation (70 °C) in TE buffer with 0.02% SDS and chromatin was phenol/chloroform extracted. Anti-H3K4me3 and antu-H3K9ac were obtained from Millipore (ref: 07473 and 06942) and anti-H3K27ac was obtained from Abcam (clone ab5131). PCR probes were the following: Eμ-forward: GGGAGTGAGGCTCTCTCATA; Eμ-reverse: ACCACAGCTACAAGTTTACCTA; hs3a-forward: GGGTAGGGCAGGGATGCTCACAT; hs3a-reverse: GCTCTGGTTTGGGGC ACCTGTGC; hs1,2-forward: AGCATAGGCCACTGGGACTGG; hs1,2-reverse: CTCTCA CTTCCCTGGGGTGTT; hs3b-forward: TGGTTTGGGGCACCTGTGCTGAG; hs3b-reverse: GGGTAGGGCAGGGATGTTCACAT; hs4-forward: CCATGGGACTGAAAC TCAGGGAACCAGAAC; hs4-reverse: CTCTGTGACTCGTCCTTAGG. PCR probes for S~μ~ C~μ~, S~γ1~, C~γ1~, S~γ3~ and C~γ3~ have been reported in a previous study^[@CR10]^.

RNAseq experiments {#Sec12}
------------------

CD43^−^ splenocytes were obtained from 4 *wt*, 4 3′RR-deficient mice and 4 E~μ~MAR-deficient mice before and after 48 h of *in vitro* stimulation (1 × 10^6^ cells per ml in RPMI 1640 with 10% fetal calf serum) with 5 μg per ml LPS. RNA was extracted using miRNeasy kit from QIAGEN, according to the manufacturer instructions. Two pooled RNA (with two samples) were obtained for each genotype. RNA libraries were obtained using TruSeq Stranded Total RNA with Ribo-Zero Gold (Illumina), according to the manufacturer instruction. Libraries were sequenced on a NextSeq500 sequencer, using NextSeq 500/550 High Output Kit (Illumina). Illumina NextSeq500 paired-end 2 × 150 nt reads were mapped with STAR release v2.4.0a versus mm10 with gene model from Ensembl release 77 with default parameters. The long length of the reads allowed for their precise mapping on switch regions, previously reported as error prone with shorter reads due to the highly repetitive structure of these sequences^[@CR34]^. Quantification of genes was then performed using feature Counts release subread-1.4.6-p1-Linux-x86_64 with "--primary -g gene_name -p -s 1 -M" options based on Ensembl GTF release 77 annotations.

Accession number {#Sec13}
----------------

Data were deposited in Gene Expression Omnibus under the accession number GSE90760.
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